[go: up one dir, main page]

ES531907A0 - Un procedimiento para la preparacion de nuevas indolonas. - Google Patents

Un procedimiento para la preparacion de nuevas indolonas.

Info

Publication number
ES531907A0
ES531907A0 ES531907A ES531907A ES531907A0 ES 531907 A0 ES531907 A0 ES 531907A0 ES 531907 A ES531907 A ES 531907A ES 531907 A ES531907 A ES 531907A ES 531907 A0 ES531907 A0 ES 531907A0
Authority
ES
Spain
Prior art keywords
indolones
phenyl
treatment
procedure
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES531907A
Other languages
English (en)
Other versions
ES8505950A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Corp Belgium
Pfizer Corp SRL
Original Assignee
Pfizer Corp Belgium
Pfizer Corp SRL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Corp Belgium, Pfizer Corp SRL filed Critical Pfizer Corp Belgium
Publication of ES531907A0 publication Critical patent/ES531907A0/es
Publication of ES8505950A1 publication Critical patent/ES8505950A1/es
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/08Indoles; Hydrogenated indoles with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/08Antiepileptics; Anticonvulsants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C43/00Ethers; Compounds having groups, groups or groups
    • C07C43/02Ethers
    • C07C43/20Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring
    • C07C43/225Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring containing halogen
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/30Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/32Oxygen atoms
    • C07D209/34Oxygen atoms in position 2
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/30Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/32Oxygen atoms
    • C07D209/38Oxygen atoms in positions 2 and 3, e.g. isatin

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Neurology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurosurgery (AREA)
  • Public Health (AREA)
  • Anesthesiology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Indole Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Dental Preparations (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
ES531907A 1982-09-20 1984-04-25 Un procedimiento para la preparacion de nuevas indolonas. Expired ES8505950A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/420,544 US4476307A (en) 1982-09-20 1982-09-20 Heteroylidene indolone compounds

Publications (2)

Publication Number Publication Date
ES531907A0 true ES531907A0 (es) 1985-06-01
ES8505950A1 ES8505950A1 (es) 1985-06-01

Family

ID=23666904

Family Applications (3)

Application Number Title Priority Date Filing Date
ES525737A Granted ES525737A0 (es) 1982-09-20 1983-09-19 Un procedimiento para la preparacion de nuevas idolonas.
ES531908A Granted ES531908A0 (es) 1982-09-20 1984-04-25 Un procedimiento para la preparacion de nuevas indolonas.
ES531907A Expired ES8505950A1 (es) 1982-09-20 1984-04-25 Un procedimiento para la preparacion de nuevas indolonas.

Family Applications Before (2)

Application Number Title Priority Date Filing Date
ES525737A Granted ES525737A0 (es) 1982-09-20 1983-09-19 Un procedimiento para la preparacion de nuevas idolonas.
ES531908A Granted ES531908A0 (es) 1982-09-20 1984-04-25 Un procedimiento para la preparacion de nuevas indolonas.

Country Status (24)

Country Link
US (1) US4476307A (es)
EP (1) EP0104860B1 (es)
JP (1) JPS5976058A (es)
KR (1) KR860001270B1 (es)
AT (1) ATE25972T1 (es)
AU (1) AU543115B2 (es)
CA (1) CA1194871A (es)
DD (1) DD213211A5 (es)
DE (1) DE3370325D1 (es)
DK (1) DK157010C (es)
ES (3) ES525737A0 (es)
FI (1) FI77446C (es)
GR (1) GR79732B (es)
HU (1) HU189747B (es)
IE (1) IE55923B1 (es)
IL (1) IL69758A (es)
NO (1) NO161557C (es)
NZ (1) NZ205638A (es)
PH (1) PH18297A (es)
PL (3) PL141370B1 (es)
PT (1) PT77360B (es)
SU (1) SU1272983A3 (es)
YU (4) YU189283A (es)
ZA (1) ZA836933B (es)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4879391A (en) * 1982-09-20 1989-11-07 Pfizer Inc. 1-Phenyl-2(1H,3H)-indolone psychotherapeutic agents
US4760083A (en) * 1986-04-10 1988-07-26 E. I. Dupont De Nemours & Company 3,3-disubstituted indolines
US5128352A (en) * 1989-01-10 1992-07-07 Pfizer Inc. Anti-inflammatory 1-heteroaryl-oxindole-3-carboxamides
US5078756A (en) * 1990-01-12 1992-01-07 Major Thomas O Apparatus and method for purification and recovery of refrigerant
US5158969A (en) * 1991-08-21 1992-10-27 Neurosearch A/S Indole derivatives as potassium channel blockers
US5760250A (en) * 1991-11-05 1998-06-02 Zeneca Limited Process for the preparation of 3-(α-methoxy)methylenebenzofuranones and intermediates therefor
DE19949209A1 (de) * 1999-10-13 2001-04-19 Boehringer Ingelheim Pharma In 5-Stellung substituierte Indolinone, ihre Herstellung und ihre Verwendung als Arzneimittel
US20030225152A1 (en) * 2001-09-27 2003-12-04 Andrews Steven W. 3-(Arylamino)methylene-1, 3-dihydro-2h-indol-2-ones as kinase inhibitors
MXPA04009365A (es) * 2002-03-27 2005-01-25 Lundbeck & Co As H Metodo para la manufactura de sertindol.
FR2847811B1 (fr) * 2002-11-29 2005-01-07 Oreal Composition filtrante contenant au moins un derive du dibenzoylmethane et au moins un derive de 3-(2-azacycloalkylidene)-1,3-dihydro-indol-2-one;procede de photostabilisation
FR2847813A1 (fr) * 2002-11-29 2004-06-04 Oreal Compositions cosmetiques photoprotectrices contenant des derives de 3-(2-azacycloalkylidene)-1,3-dihydro-indol-2-one et utilisations
US7728013B2 (en) 2005-05-10 2010-06-01 Intermune, Inc. Method of modulating stress-activated protein kinase system
ES2567283T3 (es) 2008-06-03 2016-04-21 Intermune, Inc. Compuestos y métodos para tratar trastornos inflamatorios y fibróticos
CA2747424C (en) 2008-12-19 2013-06-25 Nippon Soda Co., Ltd. 1-heterodiene derivative and harmful organism control agent
US9012493B2 (en) 2009-11-12 2015-04-21 Nippon Soda Co., Ltd. 1-heterodiene derivative and pest control agent
AR092742A1 (es) 2012-10-02 2015-04-29 Intermune Inc Piridinonas antifibroticas
JP6440625B2 (ja) 2012-11-14 2018-12-19 ザ・ジョンズ・ホプキンス・ユニバーシティー 精神分裂病を処置するための方法および組成物
CA2943363A1 (en) 2014-04-02 2015-10-08 Intermune, Inc. Anti-fibrotic pyridinones

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3506683A (en) * 1963-10-07 1970-04-14 Upjohn Co 3-(2-pyrrolidinylidene)-3h-indoles
GB1237008A (en) * 1968-12-18 1971-06-30 Pfizer Ltd Novel indoline derivatives
US3723457A (en) * 1969-09-30 1973-03-27 Eisai Co Ltd Indoline-2-one derivatives and preparation thereof
GB1374414A (en) * 1972-06-12 1974-11-20 Sterling Drug Inc 1-acyl-3-amino-alkyl-indoles and their preparation
DE2557342A1 (de) * 1975-12-19 1977-06-30 Hoechst Ag Basisch substituierte indolderivate und verfahren zu ihrer herstellung

Also Published As

Publication number Publication date
YU189283A (en) 1987-10-31
DK425383A (da) 1984-05-03
ES8505951A1 (es) 1985-06-01
EP0104860A1 (en) 1984-04-04
EP0104860B1 (en) 1987-03-18
US4476307A (en) 1984-10-09
ES8503328A1 (es) 1985-02-16
CA1194871A (en) 1985-10-08
FI77446B (fi) 1988-11-30
HU189747B (en) 1986-07-28
YU169386A (en) 1987-10-31
NO833367L (no) 1984-03-21
NZ205638A (en) 1986-12-05
PL141609B1 (en) 1987-08-31
PL250769A1 (en) 1985-07-02
FI833335A7 (fi) 1984-03-21
IE832193L (en) 1984-03-20
YU169186A (en) 1987-10-31
PL250768A1 (en) 1985-07-02
SU1272983A3 (ru) 1986-11-23
JPS5976058A (ja) 1984-04-28
DK157010C (da) 1990-03-26
IL69758A (en) 1986-12-31
YU169286A (en) 1987-10-31
IE55923B1 (en) 1991-02-27
PT77360A (en) 1983-10-01
FI77446C (fi) 1989-03-10
PL243826A1 (en) 1985-04-24
IL69758A0 (en) 1983-12-30
AU1925283A (en) 1984-03-29
PL141370B1 (en) 1987-07-31
PL141876B1 (en) 1987-09-30
NO161557B (no) 1989-05-22
PH18297A (en) 1985-05-24
KR860001270B1 (ko) 1986-09-04
DD213211A5 (de) 1984-09-05
ES525737A0 (es) 1985-02-16
ES8505950A1 (es) 1985-06-01
ES531908A0 (es) 1985-06-01
PT77360B (en) 1986-05-19
DE3370325D1 (en) 1987-04-23
ATE25972T1 (de) 1987-04-15
AU543115B2 (en) 1985-04-04
ZA836933B (en) 1985-05-29
JPS6241711B2 (es) 1987-09-04
DK157010B (da) 1989-10-30
KR840006239A (ko) 1984-11-22
NO161557C (no) 1989-08-30
FI833335A0 (fi) 1983-09-19
DK425383D0 (da) 1983-09-19
GR79732B (es) 1984-10-31

Similar Documents

Publication Publication Date Title
ES531908A0 (es) Un procedimiento para la preparacion de nuevas indolonas.
ES520988A0 (es) Procedimiento para la preparacion de nuevos 6,11-dihidro-dibenzo-(b,e)-tiepin-11-n-alcohilnorescopin-eteres.
LV10449A (lv) Jauni hromana un tiohromana atvasinajumi
DE69033703D1 (de) Nichtglykosyliertes fgf-4 und dieses enthaltende präparate
NO853698L (no) I-substituerte tetralinderivater, fremstilling og anvendel se derav.
ES545155A0 (es) Procedimiento para la obtencion de (pirrol-1-il)-fenil-dihi-dropiridazinona
IT8420213A0 (it) Procedimento per la preparazione di 1,8-diidrossi-10-acil-9-antroni, in particolare per l'uso nel trattamento di psoriasi.
ES538403A0 (es) Procedimiento para la obtencion de antipodas opticos del (+7-1,7-difenil-3-metilaza-7-ciano-8-metil-nonano
ES2188742T3 (es) Trapidil para uso en la terapia de cuadros patologicos influenciables por la inmunomodulacion.
DE3378979D1 (en) 1-acyl-3-pyridylmethylguanidines and their use as antihypertensive agents
AR010304A1 (es) Compuestos de dimesilato de cis-1-(3-etoxifenil)-1-4-fenilpiperazin-1-il) -4-metilciclohexano; procedimiento para su preparacion y composicionfarmaceutica
ES1015599Y (es) Perfil compuesto para la formacion de marcos para cuadros y similares.

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 19970401